Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Inuvo Announces Receipt of $6.2 Million Class Action Settlement
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PINEWOOD TECHNOLOGIES GROUP - Ordinary Shares
-
Anthropic and Atlassian Williams F1 Team announce multi-year partnership, naming Claude the team’s ‘Official Thinking Partner’
-
Jeffs’ Brands’ KeepZone AI Will Serve as Hydrogen-Powered Drone Systems’ Prime Contractor to Support Government and Defense Clients
-
Jeffs’ Brands’ KeepZone AI Will Serve as Hydrogen-Powered Drone Systems’ Prime Contractor to Support Government and Defense Clients
-
Garrett Motion introduces breakthrough oil-free centrifugal compressor technology for HVAC systems at AHR Expo 2026 in Las Vegas
-
In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions
-
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026
-
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
-
In Spaceflight Conditions: N2OFF‘s MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RIO TINTO PLC & RIO TINTO LIMITED - Ordinary Shares
-
Lindy Brings Complete AV/ IT Connectivity Ecosystem and Proven Expertise to US Market
-
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
-
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
-
DLH to Announce Fiscal 2026 First Quarter Financial Results
-
Carlyle to Host 2026 Shareholder Update
-
Park National Bank announces completion of First Citizens National Bank merger
-
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
-
First Merchants Corporation Completes Legal Closing of First Savings Financial Group Merger
-
Silicon Motion Confirms Quarterly Dividend
-
Total Energy Services Inc. Announces 2025 Fourth Quarter Conference Call And Webcast
-
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan
-
Freshpet, Inc. to Report Fourth Quarter and Full Year 2025 Results on Monday, February 23, 2026
-
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
-
“Global WiFi” Surpasses 24 Million Users & Celebrates 9 Consecutive Years as Japan’s No. 1
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Michael G. Smith as Chief Legal Officer and Director and Files New Federal Trademark Applications with the USPTO
-
Skyline Bankshares, Inc. Announces Fourth Quarter 2025 Results
-
Pan American Energy Selects Key Contractors to Support Planned Winter Drill Program at the Tharsis Project, Northwest Territories
-
Maxus Mining Appoints Morgan Verge as Vice President of Exploration
-
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
-
Enphase Energy Demonstrates Global IQ Bidirectional EV Charging Platform, Targeting Volume Production in Q4 2026
-
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
-
Red Cat Secures New Orders for Black Widow™ Drones from Asia-Pacific Ally
-
Enlight Reaches Final Development Milestones for CO Bar, Its Largest Project to Date
-
SunPower Secures $20 Million SEPA Agreement
-
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
-
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
-
Bitcoin Volatility Highlights Alternative Infrastructure Participation Models Such as Bitcoin Everlight
-
Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle™ Programs at the 2026 WORLDSymposium™
-
Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® (roflumilast) Cream 0.05% in Infants with Mild to Moderate Atopic Dermatitis
-
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
-
Smithsonian Journeys Announces New Trips for 2027
-
Avaap Named Snowflake Premier Partner
-
Deep Isolation Launches Full-Scale Demonstration Program for Nuclear Waste Disposal
-
Ridgeline Introduces Intelligent Operations to Power a New Operating Model for Investment Management
-
SPS Commerce Announces Date of Fourth Quarter and Fiscal Year 2025 Financial Results
-
Apollo to Present at the UBS Financial Services Conference
-
Living in California Releases 2026 Guide to Living in Los Angeles, a practical, data-informed resource designed to help future residents understand the realities of life in LA
-
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
-
Flock Safety Engages Bishop Fox to Set the Industry Standard in Cybersecurity for its Public Safety Platform
